ArticleFrontiers in public health2025
Temporal trends of knee osteoarthritis prevalence over a 7-year period in Chinese adults: findings from the CHARLS study 2011-2018.
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- The Role of Myeloperoxidase in Osteoarthritis and Its Potential Modulation by Resveratrol: An Integrated Study.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026Article
- Association between estimated cardiorespiratory fitness and arthritis in older adults: evidence from four large cohorts.Clinical rheumatology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Knee osteoarthritis (KOA) causes a heavy and increasing burden of disease worldwide. China is facing a significant burden of KOA. However, few studies have investigated the trends of KOA prevalence over time in China using nationwide field-collected data. The study aims to assess the temporal trends of symptomatic KOA prevalence from 2011 to 2018 among Chinese adults aged 45 and older using data from the China Health and Retirement Longitudinal Study (CHARLS). Method: We conducted a cross-sectional analysis using data from the 2018 wave of CHARLS to assess the prevalence of self-reported symptomatic KOA among participants. Stratified analysis was performed to identify differences across demographic subgroups. Utilizing longitudinal data from the 2011, 2015, and 2018 waves of CHARLS, we further examined the temporal trends in the standardized prevalence of self-reported symptomatic KOA within the overall population and across various demographic subgroups. Result: Among 19,015 participants form the 2018 wave of CHARLS included in the study, 3,707 (19.5%, 95%CI: 18.87-20.13%) self-reported symptomatic KOA. The prevalence generally increased with age, starting from 10.72% (95% CI: 8.51-12.93%) in the 45-49 age group and peaking at 25.55% (95% CI: 22.86%-28.46%) in the 75-79 age group, before slightly declining to 21.62% (95% CI: 19.00-24.49%) in the oldest age group (>80). Females (24.82%, 95%CI: 23.85-25.82%) exhibited a higher prevalence compared to males (13.64%, 95%CI: 12.89-14.42%). From 2011 to 2018, the standardized prevalence in the overall population increased from 9.86% (95% CI: 9.35-10.38%) to 19.5% (95% CI: 18.87-20.13%), with a rise from 12.48% (95% CI: 11.70-13.31%) to 24.82% (95% CI: 23.86-25.82%) among females and from 6.96% (95% CI: 6.37-7.61%) to 13.64% (95% CI: 12.89-14.42%) among males. Such increase was observed across all demographic subgroups. Conclusion: The study reveals a double increase in symptomatic KOA prevalence among Chinese adults aged 45 and older from 2011 to 2018. These findings provide new insights into the growing burden of KOA, despite previous research underestimating this trend. Future research on public health policies necessitates more rigorous and comprehensive studies for valuable insights.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.